secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K12B
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001193125-26-177157
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences completes holding company reorganization; shares convert 1:1 to new parent SNTI
--------------------------------------------------------------------------------

- Senti Biosciences Holdings becomes new public parent; each share of old common stock converted 1:1 into new common stock.
- Stock continues trading on Nasdaq under same ticker SNTI; new CUSIP 816944 102.
- No change in executive officers or board of directors; same management team remains in place.
- Reorganization is tax-free for shareholders; no vote required under DGCL Section 251(g).
- Business, assets, and operations of the combined entity are unchanged from pre-reorganization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000119312526177157/0001193125-26-177157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000119312526177157/d279931d8k12b.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-177157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer